Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis. Wang X, Guo T, Niu L, Zheng B, et al. Oncogene 2024 Aug 18. doi: 10.1038/s41388-024-03136.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Guo T, Niu L, Zheng B, et al. Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis. Oncogene 2024 Aug 18. doi: 10.1038/s41388-024-03136.
PMID: 39155295